NASDAQ:OACC 17 May 2026

Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story
····

Oaktree’s OACC SPAC Looks Quiet. The October Deadline Is the Real Story

Oaktree Acquisition Corp. III Life Sciences entered Wednesday’s premarket with its shares last trading at $10.62, leaving the healthcare blank-check company valued at about $261 million and still priced close to the cash value sitting behind the stock. That matters because OACC is a special purpose acquisition company, or SPAC: a listed shell that raises cash, parks it in a trust account, then looks for a private company to merge with. Its March-quarter filing showed 19.2 million redeemable Class A shares with a redemption value of $10.60 each, only a shade below the latest share price.
May 20, 2026
Oaktree SPAC draws trader attention after 5% filing
····

Oaktree SPAC draws trader attention after 5% filing

Oaktree Acquisition Corp. III Life Sciences started the new week with barely any move in the stock. The SPAC posted a new ownership filing, something that tends to shift attention for thinly traded blank-check companies. OACC’s Class A shares ended Friday flat at $10.64. Reported volume was only 10 shares. The stock trades on Nasdaq, which is closed weekends and operates from 9:30 a.m. to 4 p.m. Eastern. SPAC traders are paying attention after Fort Baker Capital Management LP said Friday it owns 1 million Class A shares, or 5.1% of the class. The disclosure came days after Oaktree Acquisition III put out quarterly numbers with no merger picked yet and an Oct. 25 deadline to get a deal done.
May 17, 2026